SEC Filing Summary: Common Horizons, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Common Horizons, Inc. on May 27, 2005, reporting events occurring on May 24 and May 25, 2005. The registrant is incorporated in Nevada with principal executive offices in Las Vegas. Note: The input metadata references "Cellectar Biosciences, Inc.," but the filing text explicitly identifies the registrant as "Common Horizons, Inc."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate capital structure event.
Material Changes
- Stock Split: The Board of Directors approved a 4-for-1 forward stock split.
- Authorized Shares: Increased from 25,000,000 to 100,000,000.
- Issued and Outstanding Shares: Increased proportionately from 10,500,000 to 42,000,000.
- Record Date: May 25, 2005. Shareholders of record will receive three additional shares for each share owned.
- Implementation: New share certificates are expected to be distributed on or about June 10, 2005.
- Regulatory Action: Amended articles of incorporation were filed with the State of Nevada. Shareholder approval was not required under Nevada Revised Statutes.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items beyond the stock split event.
Investor Verification Checklist
- Verify the correct registrant name (Common Horizons, Inc.) versus the metadata label (Cellectar Biosciences, Inc.).
- Confirm the 4-for-1 split ratio and the new total share count of 42,000,000.
- Check the distribution date for new stock certificates (June 10, 2005).
- Review the amended articles of incorporation filed with the State of Nevada.